Do Type and Duration of Antiretroviral Therapy Attenuate Liver Fibrosis in HIV--Hepatitis C Virus--Coinfected Patients?
Open Access
- 15 January 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (2) , 262-270
- https://doi.org/10.1086/499055
Abstract
Background. This study aimed to determine whether type and duration of therapy for human immunodeficiency virus (HIV) infection attenuates liver fibrKeywords
This publication has 24 references indexed in Scilit:
- Survival in patients with HIV infection and viral hepatitis B or CAIDS, 2004
- Impact of highly active antiretroviral therapy on the spectrum of liver disease in hcv-hiv coinfectionClinical Gastroenterology and Hepatology, 2004
- Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfectionThe Lancet, 2003
- Hepatitis C and human immunodeficiency virus infectionHepatology, 2002
- Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials GroupClinical Infectious Diseases, 2002
- Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐AnalysisClinical Infectious Diseases, 2001
- Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2001
- Mortality for Liver Disease in Patients With HIV Infection: A Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Human immunodeficiency virus infection modified the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosisJournal of Hepatology, 1997